Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis

por Lancaster, Lisa H.
Publicado 2018

Acupuncture Points of the Horse’s Distal Thoracic Limb: A Neuroanatomic Approach to the Transposition of Traditional Points

por Lancaster, Lisa S., Bowker, Robert M.
Publicado 2012

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)

por Copeland, Carla R., Lancaster, Lisa H.
Publicado 2021

Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden

por Lancaster, Lisa, Bonella, Francesco, Inoue, Yoshikazu, Cottin, Vincent, Siddall, James, Small, Mark, Langley, Jonathan
Publicado 2021

Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program

por Lancaster, Lisa, Morrison, Lake, Auais, Alexander, Ding, Beiying, Iqbal, Ahmar, Polman, Boris, Flaherty, Kevin R.
Publicado 2017

Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey

por Lancaster, Lisa H., Valenzuela, Claudia, Mason, Wendi, Neurohr, Claus, Ripamonti, Elena, Kirchgaessler, Klaus-Uwe, Cottin, Vincent
Publicado 2020

Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials

por Lancaster, Lisa, Crestani, Bruno, Hernandez, Paul, Inoue, Yoshikazu, Wachtlin, Daniel, Loaiza, Lazaro, Quaresma, Manuel, Stowasser, Susanne, Richeldi, Luca
Publicado 2019

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD

por Kolb, Martin, Orfanos, Stylianos E., Lambers, Chris, Flaherty, Kevin, Masters, Alison, Lancaster, Lisa, Silverstein, Adam, Nathan, Steven D.
Publicado 2022

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

por Nathan, Steven D, Behr, Jurgen, Cottin, Vincent, Lancaster, Lisa, Smith, Peter, Deng, CQ, Pearce, Natalie, Bell, Heidi, Peterson, Leigh, Flaherty, Kevin R
Publicado 2022

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

por Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K., Lancaster, Lisa H., Wuyts, Wim A., Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W.
Publicado 2019

Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies

por Behr, Jürgen, Nathan, Steven D., Costabel, Ulrich, Albera, Carlo, Wuyts, Wim A., Glassberg, Marilyn K., Haller, Harold, Alvaro, Giuseppe, Gilberg, Frank, Samara, Katerina, Lancaster, Lisa
Publicado 2023

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis

por Lancaster, Lisa, Goldin, Jonathan, Trampisch, Matthias, Kim, Grace Hyun, Ilowite, Jonathan, Homik, Lawrence, Hotchkin, David L., Kaye, Mitchell, Ryerson, Christopher J., Mogulkoc, Nesrin, Conoscenti, Craig S
Publicado 2020

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository

por Farber, Harrison W., Chakinala, Murali M., Cho, Michelle, Frantz, Robert P., Frick, Andrew, Lancaster, Lisa, Milligan, Scott, Oudiz, Ronald, Panjabi, Sumeet, Tsang, Yuen, Nathan, Steven D.
Publicado 2023

Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials

por Nathan, Steven D, Lancaster, Lisa H, Albera, Carlo, Glassberg, Marilyn K, Swigris, Jeffrey J, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Limb, Susan L, Petzinger, Ute, Noble, Paul W
Publicado 2018

Peripheral Blood Telomere Attrition in Persons at Risk for Familial Pulmonary Fibrosis

por Salisbury, Margaret L., Markin, Cheryl R., Wu, Pingsheng, Cogan, Joy D., Mitchell, Daphne B., Liu, Qi, Loyd, James E., Lancaster, Lisa H., Kropski, Jonathan A., Blackwell, Timothy S.
Publicado 2022

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Regis...

por Case, Amy Hajari, Hellkamp, Anne S., Neely, Megan L., Bender, Shaun, Dilling, Daniel F., Gulati, Mridu, Hotchkin, David L., Huie, Tristan J., Lancaster, Lisa, Snyder, Laurie D., Conoscenti, Craig S.
Publicado 2020

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

por Lancaster, Lisa H., de Andrade, Joao A., Zibrak, Joseph D., Padilla, Maria L., Albera, Carlo, Nathan, Steven D., Wijsenbeek, Marlies S., Stauffer, John L., Kirchgaessler, Klaus-Uwe, Costabel, Ulrich
Publicado 2017

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation

por Maher, Toby M., Lancaster, Lisa H., Jouneau, Stéphane, Morrison, Lake, Lederer, David J., Molina-Molina, Maria, Bendstrup, Elisabeth, Kirchgaessler, Klaus-Uwe, Gilberg, Frank, Axmann, Judit, Petzinger, Ute, Noble, Paul W.
Publicado 2019

Identification of a Genetic Susceptibility Locus for Idiopathic Pulmonary Fibrosis in the 16p Subtelomere Using Whole-Genome Sequencing

por Donoghue, Lauren J., Stockwell, Amy D., Neighbors, Margaret, Sheng, Rebecca X., Prabhakaran, Ramanandan, Wolters, Paul J., Lancaster, Lisa H., Kropski, Jonathan A., Blackwell, Timothy S., McCarthy, Mark I., Yaspan, Brian L.
Publicado 2023

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry

por Snyder, Laurie D, Mosher, Christopher, Holtze, Colin H, Lancaster, Lisa H, Flaherty, Kevin R, Noth, Imre, Neely, Megan L, Hellkamp, Anne S, Bender, Shaun, Conoscenti, Craig S, de Andrade, Joao A, Whelan, Timothy PM
Publicado 2020